> Cost of entry is immense. As with anything medical or food and drug related, there are large (and expensive) obstacles to hurdle before any product can enter the market.
What about not using the US as the launch market?
What about not using the US as the launch market?
Edit: I may have misread your comment, my apologies! I'm only loosely familiar with the US regulation on this matter and completely unfamiliar with other countries' regulations but I'd find it hard to believe there's any country more expensive to launch in for a medical device than the US, so for the OP I'd agree with you that the US should probably be a later market to target.
https://www.fda.gov/news-events/press-announcements/fda-fina...
https://www.federalregister.gov/documents/2022/08/17/2022-17...